Related references
Note: Only part of the references are listed.Systematic mapping review of guidelines for BRCA1/2 genetic testing globally: investigating geographic and regional disparities in health equity for women and families at risk for hereditary ovarian cancer
Brittany N. Hughes et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)
Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India
Divya Pillai et al.
CANCERS (2023)
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
Susana Banerjee et al.
LANCET ONCOLOGY (2021)
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
Pascal Pujol et al.
EUROPEAN JOURNAL OF CANCER (2021)
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study
Dhivya Chandrasekaran et al.
CANCERS (2021)
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom
Sudha Sundar et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations
Kathleen N. Moore et al.
GYNECOLOGIC ONCOLOGY (2020)
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A randomized controlled trial of video-education or in-person genetic counseling for men with prostate cancer (ProGen).
Huma Q. Rana et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention
Faiza Gaba et al.
CANCERS (2020)
Standards for UNiversal reporting of patient Decision Aid Evaluation studies: the development of SUNDAE Checklist
Karen R. Sepucha et al.
BMJ QUALITY & SAFETY (2018)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial
Veronica F. Quinn et al.
GENETICS IN MEDICINE (2017)
National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer
Christopher P. Childers et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)
Philipp Harter et al.
PLOS ONE (2017)
Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey study
Susanne F. Meisel et al.
BMC PUBLIC HEALTH (2017)
Video-assisted genetic counseling in patients with ovarian, fallopian and peritoneal carcinoma
Catherine H. Watson et al.
GYNECOLOGIC ONCOLOGY (2016)
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations
Ranjit Manchanda et al.
JOURNAL OF MEDICAL GENETICS (2016)
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
Jonathan A. Ledermann et al.
LANCET ONCOLOGY (2016)
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients
Angela George et al.
SCIENTIFIC REPORTS (2016)
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions
Johnathan M. Lancaster et al.
GYNECOLOGIC ONCOLOGY (2015)
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the US Preventive Services Task Force Recommendation
Heidi D. Nelson et al.
ANNALS OF INTERNAL MEDICINE (2014)
A systematic development process for patient decision aids
Angela Coulter et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2013)
Communication and Information Needs of Women Diagnosed With Ovarian Cancer Regarding Treatment-Focused Genetic Testing
Margaret Gleeson et al.
ONCOLOGY NURSING FORUM (2013)
A pre-visit website with question prompt sheet for counselees facilitates communication in the first consultation for breast cancer genetic counseling: findings from a randomized controlled trial
Akke Albada et al.
GENETICS IN MEDICINE (2012)
A counselee-oriented perspective on risk communication in genetic counseling: Explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure
Joel Vos et al.
GENETICS IN MEDICINE (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Assessing the Quality of Decision Support Technologies Using the International Patient Decision Aid Standards instrument (IPDASi)
Glyn Elwyn et al.
PLOS ONE (2009)
Perceptions of cancer-related information among cancer survivors - A report from the American Cancer Society's studies of cancer survivors
D. Keith MeInnes et al.
CANCER (2008)
A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling
Claire F. Wakefield et al.
PSYCHO-ONCOLOGY (2008)
Genetic susceptibility to breast cancer
Angela R. Bradbury et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2007)
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing
Julien Mancini et al.
EUROPEAN JOURNAL OF CANCER (2006)
Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes
EA Lobb et al.
BRITISH JOURNAL OF CANCER (2004)